As of April 2024 Merck has a market cap of $331.11 Billion. This makes Merck the world's 26th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $331.11 B | 19.86% |
2023 | $276.25 B | -1.79% |
2022 | $281.30 B | 45.31% |
2021 | $193.58 B | -6.46% |
2020 | $206.95 B | -10.38% |
2019 | $230.92 B | 16.57% |
2018 | $198.09 B | 29.22% |
2017 | $153.30 B | -5.55% |
2016 | $162.31 B | 10.49% |
2015 | $146.89 B | -8.86% |
2014 | $161.17 B | 10% |
2013 | $146.52 B | 18.25% |
2012 | $123.91 B | 7.84% |
2011 | $114.90 B | 3.45% |
2010 | $111.07 B | -2.2% |
2009 | $113.57 B | 76.71% |
2008 | $64.27 B | -49.09% |
2007 | $126.24 B | 33.57% |
2006 | $94.51 B | 36.18% |
2005 | $69.40 B | -2.22% |
2004 | $70.98 B | -30.84% |
2003 | $102.64 B | -19.46% |
2002 | $127.44 B | -6.04% |
2001 | $135.63 B |
On Apr 24th, 2024 the market cap of Merck was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $353.80 B | 6.85% | ๐บ๐ธ USA |
Novartis NVS | $202.12 B | -38.96% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.03 B | -56.80% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $185.42 B | -44.00% | ๐บ๐ธ USA |
Eli Lilly LLY | $689.18 B | 108.14% | ๐บ๐ธ USA |
Amgen AMGN | $144.48 B | -56.36% | ๐บ๐ธ USA |
Sanofi SNY | $125.12 B | -62.21% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $90.59 B | -72.64% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.58 B | -74.76% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.00 B | -95.47% | ๐ฎ๐ฑ Israel |